Wang Xiaogang - Net Worth and Insider Trading

Wang Xiaogang Net Worth

The estimated net worth of Wang Xiaogang is at least $6 Million dollars as of 2025-04-18. Wang Xiaogang is the 2101 Beneficial owner of China Regenerative Medicine International Ltd and owns about 14,945,000 shares of China Regenerative Medicine International Ltd (HKSE:08158) stock worth over $6 Million. Details can be seen in Wang Xiaogang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wang Xiaogang has not made any transactions after 2020-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Wang Xiaogang

Wang Xiaogang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wang Xiaogang owns 1 companies in total, including China Regenerative Medicine International Ltd (HKSE:08158) .

Click here to see the complete history of Wang Xiaogang’s form 4 insider trades.

Insider Ownership Summary of Wang Xiaogang

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:08158	China Regenerative Medicine International Ltd	2020-12-15	2101 Beneficial owner

Wang Xiaogang Latest Holdings Summary

Wang Xiaogang currently owns a total of 1 stock. Wang Xiaogang owns 14,945,000 shares of China Regenerative Medicine International Ltd (HKSE:08158) as of December 15, 2020, with a value of $6 Million.

Latest Holdings of Wang Xiaogang

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:08158	China Regenerative Medicine International Ltd	2020-12-15	14,945,000	0.43	6,351,625

Holding Weightings of Wang Xiaogang

Wang Xiaogang Form 4 Trading Tracker

According to the SEC Form 4 filings, Wang Xiaogang has made a total of 1 transactions in China Regenerative Medicine International Ltd (HKSE:08158) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in China Regenerative Medicine International Ltd is the sale of 0 shares on December 15, 2020, which brought Wang Xiaogang around $0.

Insider Trading History of Wang Xiaogang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wang Xiaogang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wang Xiaogang Ownership Network

Ownership Network List of Wang Xiaogang

No Data

Ownership Network Relation of Wang Xiaogang

Wang Xiaogang Owned Company Details

What does China Regenerative Medicine International Ltd do?

Who are the key executives at China Regenerative Medicine International Ltd?

Wang Xiaogang is the 2101 Beneficial owner of China Regenerative Medicine International Ltd. Other key executives at China Regenerative Medicine International Ltd include 2201 Interest of corporation controlled by you Central Huijin Investment Ltd. , 2101 Beneficial owner Wang Chuang , and 2501 Other Arab Osman Mohammed .

China Regenerative Medicine International Ltd (HKSE:08158) Insider Trades Summary

Over the past 18 months, Wang Xiaogang made no insider transaction in China Regenerative Medicine International Ltd (HKSE:08158). Other recent insider transactions involving China Regenerative Medicine International Ltd (HKSE:08158) include a net sale of 0 shares made by Central Huijin Investment Ltd. , and a net sale of 0 shares made by Wang Chuang .

In summary, during the past 3 months, insiders sold 0 shares of China Regenerative Medicine International Ltd (HKSE:08158) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Regenerative Medicine International Ltd (HKSE:08158) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

China Regenerative Medicine International Ltd (HKSE:08158)'s detailed insider trading history can be found in Insider Trading Tracker table.

China Regenerative Medicine International Ltd Insider Transactions

No Available Data

Wang Xiaogang Mailing Address

Above is the net worth, insider trading, and ownership report for Wang Xiaogang. Currently GuruFocus does not have mailing address information for Wang Xiaogang.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.